• Earlier this month, United States Antimony announced it would release its Q1 2026 results on May 14 and host an earnings call the same day to update investors on its operations.
• Investor attention has recently centered on a report highlighting United States Antimony’s very large decade-long compounded return, underscoring how long-term holding can materially reshape investment outcomes.
• We’ll now examine how this renewed focus on United States Antimony’s long-term compounding record may influence the company’s broader investment narrative.

Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

United States Antimony Investment Narrative Recap

To own United States Antimony, you need to believe in its role as a vertically integrated supplier of critical minerals and antimony products, despite current unprofitability and a rich valuation. The upcoming Q1 2026 earnings release and call may clarify how recent margin pressure, permitting challenges and supply chain constraints are tracking, but do not fundamentally change the near term picture where execution on expansion projects is the key catalyst and operational or regulatory setbacks remain the biggest risks.

The most relevant recent announcement here is the February 2026 joint venture with Americas Gold and Silver to build an antimony processing plant in Idaho’s Silver Valley. That project sits at the heart of the growth story because it could increase domestic processing capacity and support higher throughput, directly tying into the compounding narrative investors are focused on, while also magnifying the impact of any permitting, feedstock or cost overruns on future results.

Yet behind the strong long term return profile, investors should also be aware of the risk that permitting delays at key projects could...

United States Antimony's narrative projects $327.7 million revenue and $84.7 million earnings by 2029.

Uncover how United States Antimony's forecasts yield a $12.67 fair value, a 27% upside to its current price.

Exploring Other Perspectives

Before today’s call, the most optimistic analysts were assuming revenue could reach about US$333 million and earnings US$71.5 million, which is far more bullish than the more cautious view that highlights permitting, throughput and contract concentration risks; your own take may shift as new information from the Q1 2026 update either supports or challenges these very different expectations.

Explore 18 other fair value estimates on United States Antimony - why the stock might be worth less than half the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your United States Antimony research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free United States Antimony research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate United States Antimony's overall financial health at a glance.

Contemplating Other Strategies?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Find 46 companies with promising cash flow potential yet trading below their fair value.
• Uncover the next big thing with 28 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.